文献速递急性肾损伤

整合临床与生物标志物的危重成人严重AKI预测模型

A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-03-27

该研究基于两个前瞻性危重患者队列,用LASSO回归开发并验证预测ICU入住后72小时内严重AKI的风险模型。衍生队列1075例,外部验证队列262例。三变量模型ACT(年龄、肝硬化、可溶性TNF受体-1)在衍生队列c-statistic为0.95,内部验证0.90,外部验证0.93。

要点

  • ACT模型仅含年龄、肝硬化、可溶性TNF受体-1三变量。
  • 严重AKI定义为KDIGO 2或3期,各队列发生率8%、8%、6%。
  • ACT模型阴性预测值高(0.94-0.95),阳性预测值中等(0.50-0.95)。

核心结论

  • ACT模型简单稳健,可用于改善危重AKI患者的风险预后并优化临床试验入组。

研究设计与样本

  • 研究采用LASSO回归方法,在1075例患者中衍生并内部验证风险模型,在262例患者中外部验证。
  • 两个前瞻性队列纳入符合全身炎症反应综合征标准的危重患者,于入院后24-48小时内入组。
  • 预测模型使用人口学、实验室及炎症或内皮功能障碍血浆生物标志物。

主要发现

  • 衍生队列中严重AKI发生62例(8%),内部验证26例(8%),外部验证15例(6%)。
  • 衍生队列三变量模型(年龄、肝硬化、可溶性TNF受体-1浓度[ACT])c-statistic为0.95(95%CI 0.91-0.97)。
  • ACT模型内部验证c-statistic为0.90(95%CI 0.82-0.96),外部验证为0.93(95%CI 0.89-0.97)。
  • ACT模型在三个队列中对严重AKI的阳性预测值为0.50-0.95,阴性预测值为0.94-0.95。

关键数值与推荐

  • 严重AKI定义为KDIGO分期2或3期。
  • 预测时间窗为ICU入住后72小时内。

临床怎么用

  • ACT模型可用于危重患者严重AKI风险分层,高阴性预测值有助于排除低风险患者。
  • 该模型或可辅助临床试验筛选高危受试者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Critically ill patients with worsening AKI are at high risk for poor outcomes. Predicting which patients will experience progression of AKI remains elusive. We sought to develop and validate a risk model for predicting severe AKI within 72 hours after intensive care unit admission. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We applied least absolute shrinkage and selection operator regression methodology to two prospectively enrolled, critically ill cohorts of patients who met criteria for the systemic inflammatory response syndrome, enrolled within 24-48 hours after hospital admission. The risk models were derived and internally validated in 1075 patients and externally validated in 262 patients. Demographics and laboratory and plasma biomarkers of inflammation or endothelial dysfunction were used in the prediction models. Severe AKI was defined as Kidney Disease Improving Global Outcomes (KDIGO) stage 2 or 3. RESULTS: Severe AKI developed in 62 (8%) patients in the derivation, 26 (8%) patients in the internal validation, and 15 (6%) patients in the external validation cohorts. In the derivation cohort, a three-variable model (age, cirrhosis, and soluble TNF receptor-1 concentrations [ACT]) had a c-statistic of 0.95 (95% confidence interval [95% CI], 0.91 to 0.97). The ACT model performed well in the internal (c-statistic, 0.90; 95% CI, 0.82 to 0.96) and external (c-statistic, 0.93; 95% CI, 0.89 to 0.97) validation cohorts. The ACT model had moderate positive predictive values (0.50-0.95) and high negative predictive values (0.94-0.95) for severe AKI in all three cohorts. CONCLUSIONS: ACT is a simple, robust model that could be applied to improve risk prognostication and better target clinical trial enrollment in critically ill patients with AKI.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bhatraju PK, Zelnick LR, Katz R, et al. A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data. Clin J Am Soc Nephrol. 2019. PMID: 30917991. doi:10.2215/CJN.04100318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。